Novo Nordisk===Semaglutide

Novo Nordisk===Semaglutide, a Novo Nordisk drug, is also being used off-label for cosmetic weight loss in India. The availability of cheaper generic versions of its active ingredient, semaglutide, is widening access and exacerbating misuse concerns.

Novo Nordisk===Semaglutide, a semaglutide drug, is highlighted in the study for its cardiovascular benefits when used continuously, but also for the risks associated with its discontinuation. The study emphasizes the need for long-term adherence, which could impact sales if patients are deterred by the commitment.

Novo Nordisk===Semaglutide, an oral semaglutide tablet, showed no increased risk of NAION in the study. Its limited absorption and slower uptake are suggested as reasons for this, potentially positioning it as a safer alternative within the semaglutide family for this specific side effect.